Protara Therapeutics Inc (TARA)
2.80
-0.10
(-3.45%)
USD |
NASDAQ |
May 31, 16:00
2.90
+0.10
(+3.57%)
After-Hours: 20:00
Protara Therapeutics Free Cash Flow: -35.05M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -35.05M |
| December 31, 2023 | -37.60M |
| September 30, 2023 | -33.93M |
| June 30, 2023 | -32.77M |
| March 31, 2023 | -28.50M |
| December 31, 2022 | -26.58M |
| September 30, 2022 | -28.50M |
| Date | Value |
|---|---|
| June 30, 2022 | -29.20M |
| March 31, 2022 | -33.86M |
| December 31, 2021 | -35.10M |
| September 30, 2021 | -35.42M |
| June 30, 2021 | -33.18M |
| March 31, 2021 | -29.11M |
| December 31, 2020 | -24.29M |
Free Cash Flow Range, Past 5 Years
-37.60M
Minimum
Dec 2023
-24.29M
Maximum
Dec 2020
-31.65M
Average
-32.97M
Median
Free Cash Flow Benchmarks
| AngioDynamics Inc | -23.46M |
| Regulus Therapeutics Inc | -28.24M |
| Bio-Path Holdings Inc | -8.92M |
| Outset Medical Inc | -135.51M |
| NovaBay Pharmaceuticals Inc | -4.524M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -10.38M |
| Cash from Investing (Quarterly) | 23.10M |
| Cash from Financing (Quarterly) | -0.076M |
| Free Cash Flow Per Share (Quarterly) | -0.9088 |
| Free Cash Flow Yield | -110.2% |